The 340B program allows qualifying safety net providers that serve a high proportion of low-income, uninsured, and underinsured patients to purchase outpatient drugs at a discounted price from pharmaceutical manufacturers. GNYHA continues to educate lawmakers on the importance of the 340B program, and will keep members informed on program updates.
10 Items in 340B Program
Federal Court Blocks Implementation of “Most-Favored Nation” Drug Pricing Model; GNYHA Comments on Interim Final Rule
February 1, 2021
CMS Proposes Additional 340B Drug Cuts, Makes Certain Telehealth Provisions Permanent, and Responds to Allina Ruling
August 6, 2020